Literature DB >> 22954346

Antigenic differences between vaccine and circulating wild-type mumps viruses decreases neutralization capacity of vaccine-induced antibodies.

M Šantak1, M Lang-Balija, J Ivancic-Jelecki, T Košutić-Gulija, S Ljubin-Sternak, D Forcic.   

Abstract

A recent resurgence of mumps in doubly vaccinated cohorts has been observed, identifying genotype G as the current predominant genotype. In this study, the neutralization efficacy of guinea pig sera immunized with three vaccine viruses: L-Zagreb, Urabe AM9 and JL5, was tested against seven mumps viruses: three vaccine strains and four wild-type strains (two of genotype G, one of genotype C, one of genotype D) isolated during 1998-2011. All sera neutralized all viruses although at different levels. The neutralization efficiency of sera decreases several fold by temporal order of virus isolation. Therefore, we concluded that gradual evolution of mumps viruses, rather than belonging to a certain genotype, results in an antigenic divergence from the vaccine strains that decrease the neutralization capacity of vaccine-induced antibodies. Moreover, the amino-acid sequence alignment revealed three new potentially relevant regions for escape from neutralization, i.e. 113-130, 375-403 and 440-443.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22954346      PMCID: PMC9151871          DOI: 10.1017/S0950268812001896

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  33 in total

1.  Localization of a new neutralizing epitope on the mumps virus hemagglutinin-neuraminidase protein.

Authors:  M G Cusi; S Fischer; R Sedlmeier; M Valassina; P E Valensin; M Donati; W J Neubert
Journal:  Virus Res       Date:  2001-04       Impact factor: 3.303

2.  Mumps virus.

Authors:  K CANTELL
Journal:  Adv Virus Res       Date:  1961       Impact factor: 9.937

3.  Mumps vaccine effectiveness in primary schools and households, the Netherlands, 2008.

Authors:  Bianca E P Snijders; Alies van Lier; Jan van de Kassteele; Ewout B Fanoy; Wilhelmina L M Ruijs; Folkwin Hulshof; Annet Blauwhof; Maarten Schipper; Rob van Binnendijk; Hein J Boot; Hester E de Melker; Susan J M Hahné
Journal:  Vaccine       Date:  2012-02-27       Impact factor: 3.641

4.  Ongoing mumps outbreak in a student population with high vaccination coverage, Netherlands, 2010.

Authors:  J Whelan; R van Binnendijk; K Greenland; E Fanoy; M Khargi; K Yap; H Boot; N Veltman; C Swaan; A van der Bij; H de Melker; S Hahné
Journal:  Euro Surveill       Date:  2010-04-29

5.  Mumps vaccine L-Zagreb, prepared in chick fibroblasts. I. Production and field trials.

Authors:  M Beck; R Welsz-Malecek; M Mesko-Prejac; V Radman; M Juzbasic; M Rajninger-Miholic; M Prislin-Musklic; V Dobrovsak-Sourek; S Smerdel; D W Stainer
Journal:  J Biol Stand       Date:  1989-01

6.  Hemagglutinin-neuraminidase (HN) amino acid alterations in neutralization escape mutants of Kilham mumps virus.

Authors:  J Kövamees; R Rydbeck; C Orvell; E Norrby
Journal:  Virus Res       Date:  1990-10       Impact factor: 3.303

7.  Mumps outbreak in Jerusalem affecting mainly male adolescents.

Authors:  C Stein-Zamir; H Shoob; N Abramson; E Tallen-Gozani; I Sokolov; G Zentner
Journal:  Euro Surveill       Date:  2009-12-17

8.  Comparisons of mumps virus potency estimates obtained by 50% cell culture infective dose assay and plaque assay.

Authors:  Dubravko Forcic; Tanja Kosutić-Gulija; Maja Santak; Renata Jug; Jelena Ivancic-Jelecki; Maja Markusic; Renata Mazuran
Journal:  Vaccine       Date:  2009-12-02       Impact factor: 3.641

9.  Antigenic and genetic variation of the HN protein of mumps virus strains.

Authors:  P J Yates; M A Afzal; P D Minor
Journal:  J Gen Virol       Date:  1996-10       Impact factor: 3.891

10.  Investigation of a mumps outbreak among university students with two measles-mumps-rubella (MMR) vaccinations, Virginia, September-December 2006.

Authors:  J S Rota; J C Turner; M K Yost-Daljev; M Freeman; D M Toney; E Meisel; N Williams; S B Sowers; L Lowe; P A Rota; L A Nicolai; L Peake; W J Bellini
Journal:  J Med Virol       Date:  2009-10       Impact factor: 2.327

View more
  20 in total

1.  Factors influencing preclinical in vivo evaluation of mumps vaccine strain immunogenicity.

Authors:  B Halassy; T Kurtović; M Brgles; M Lang Balija; D Forčić
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Immunogenicity of novel mumps vaccine candidates generated by genetic modification.

Authors:  Pei Xu; Zhenhai Chen; Shannon Phan; Adrian Pickar; Biao He
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

3.  Monitoring Viral Genetic Variation as a Tool To Improve Molecular Diagnostics for Mumps Virus.

Authors:  Meik Dilcher; Kevin Barratt; Jennifer Douglas; Andrew Strathdee; Trevor Anderson; Anja Werno
Journal:  J Clin Microbiol       Date:  2018-09-25       Impact factor: 5.948

4.  Genomic characterization of mumps viruses from a large-scale mumps outbreak in Arkansas, 2016.

Authors:  Duah Alkam; Piroon Jenjaroenpun; Thidathip Wongsurawat; Zulema Udaondo; Preecha Patumcharoenpol; Michael Robeson; Dirk Haselow; William Mason; Intawat Nookaew; David Ussery; Se-Ran Jun
Journal:  Infect Genet Evol       Date:  2019-07-15       Impact factor: 3.342

Review 5.  Exploring the Mumps Virus Glycoproteins: A Review.

Authors:  Jasmine Rae Frost; Saba Shaikh; Alberto Severini
Journal:  Viruses       Date:  2022-06-18       Impact factor: 5.818

Review 6.  Knowledge gaps persist and hinder progress in eliminating mumps.

Authors:  R Ramanathan; E A Voigt; R B Kennedy; G A Poland
Journal:  Vaccine       Date:  2018-05-18       Impact factor: 4.169

7.  Molecular characteristics of mumps viruses isolated in Taiwan from 2006 to 2016.

Authors:  Wen-Yueh Cheng; Ming-Tsan Liu
Journal:  Heliyon       Date:  2018-02-08

8.  Are cases of mumps in vaccinated patients attributable to mismatches in both vaccine T-cell and B-cell epitopes?: An immunoinformatic analysis.

Authors:  E Jane Homan; Robert D Bremel
Journal:  Hum Vaccin Immunother       Date:  2013-11-25       Impact factor: 3.452

9.  Cross-neutralization between three mumps viruses & mapping of haemagglutinin-neuraminidase (HN) epitopes.

Authors:  Sunil R Vaidya; Garima M Dvivedi; Santoshkumar M Jadhav
Journal:  Indian J Med Res       Date:  2016-01       Impact factor: 2.375

10.  Laboratory testing and phylogenetic analysis during a mumps outbreak in Ontario, Canada.

Authors:  Arnaud G L'Huillier; Alireza Eshaghi; C Sarai Racey; Katherene Ogbulafor; Ernesto Lombos; Rachel R Higgins; David C Alexander; Erik Kristjanson; Jocelyn Maregmen; Jonathan B Gubbay; Tony Mazzulli
Journal:  Virol J       Date:  2018-06-05       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.